Dual antiplatelet platelet therapy duration following coronary stenting

Journal of the American College of Cardiology

Volumn 65, Issue 8, 2015, Pages 787-790

  Yeh, Robert W ^a   Mauri, Laura ^b   Kereiakes, Dean J ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c The Carl & Edyth Lindner Center for Research & Education   (United States)

Author keywords

drug eluting stent(s); percutaneous coronary angioplasty

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; EVEROLIMUS; PACLITAXEL; PLACEBO; PRASUGREL; RAPAMYCIN; ZOTAROLIMUS; TICLOPIDINE;

BLEEDING; CARDIOVASCULAR MORTALITY; CORONARY STENTING; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; DRUG ELUTING CORONARY STENT; DRUG SAFETY; DRUG THERAPY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DUAL ANTIPLATELET THERAPY; HEART INFARCTION; HUMAN; NOTE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; RISK REDUCTION; STENT THROMBOSIS; TREATMENT DURATION; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FEMALE; MALE; PERCUTANEOUS CORONARY INTERVENTION; RESTENOSIS;

ASPIRIN; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HEMORRHAGE; HUMANS; MALE; PERCUTANEOUS CORONARY INTERVENTION; TICLOPIDINE;

EID: 84923361792     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.01.004     Document Type: Editorial

References (13)

1. G.N. Levine, E.R. Bates, and J.C. Blankenship 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions J Am Coll Cardiol 58 2011 e44 e122
2. S.J. Park, D.W. Park, and Y.H. Kim Duration of dual antiplatelet therapy after implantation of drug-eluting stents N Engl J Med 362 2010 1374 1382
3. H.C. Gwon, J.Y. Hahn, and K.W. Park Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the efficacy of Xience/Promus versus cypher to reduce late loss after stenting (EXCELLENT) randomized, multicenter study Circulation 125 2012 505 513
4. M. Valgimigli, G. Campo, and M. Monti Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial Circulation 125 2012 2015 2026
5. F. Feres, R.A. Costa, and A. Abizaid Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial JAMA 310 2013 2510 2522
6. A. Colombo, A. Chieffo, and A. Frasheri Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial J Am Coll Cardiol 64 2014 2086 2097
7. S. Schüpke, J. Mehilli, and K.-L. Laugwitz Randomized, double blind trial of 6 versus 12 months of dual antiplatelet therapy after DES-implantation (ISAR-SAFE) Circulation 130 2014 2105 2126
8. M. Gilard, P. Barragan, and A.A.L. Noryani 6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial J Am Coll Cardiol 65 2015 777 786
9. J. LeLorier, G. Gregoire, A. Benhaddad, J. Lapierre, and F. Derderian Discrepancies between meta-analyses and subsequent large randomized, controlled trials N Engl J Med 337 1997 536 542
10. L. Mauri, D.J. Kereiakes, and R.W. Yeh Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents N Engl J Med 371 2014 2155 2166
11. T. Palmerini, G. Biondi-Zoccai, and D. Della Riva Stent thrombosis with drug-eluting and bare-metal stents: Evidence from a comprehensive network meta-analysis Lancet 379 2012 1393 1402
12. P. Garg, B.Z. Galper, D.J. Cohen, R.W. Yeh, and L. Mauri Balancing the risks of bleeding and stent thrombosis: a decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stents Am Heart J 169 2015 222 233
13. A. Colombo, and A. Chieffo Dual antiplatelet therapy after drug-eluting stents - how long to treat? N Engl J Med 371 2014 2225 2226